Filing Details
- Accession Number:
- 0000950170-23-071911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-20 16:41:48
- Reporting Period:
- 2023-12-18
- Accepted Time:
- 2023-12-20 16:41:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1569225 | Jeff Castelli | 47 Hulfish Street Princeton NJ 08542 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-18 | 8,643 | $0.00 | 377,236 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-12-19 | 17,500 | $13.25 | 359,736 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-12-20 | 1,654 | $13.10 | 358,082 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents a contingent right to receive common stock in the amount shown, for no consideration, due to the satisfaction of performance criteria underlying an award of performance based restricted stock units granted in 2021. Such units remain outstanding on the date hereof and will fully vest on December 31, 2023, subject to the Reporting Person's continued service with the Company.
Billionaire Hedge Funds
